Pall Launches New Fluid Management Technologies for the Biopharmaceutical Industry at INTERPHEX2007

    EAST HILLS, N.Y., April 25 /CNW/ - The increasing focus on biotechnology
and personalized medicines along with the growth of the vaccine marketplace is
changing the face of the biopharmaceutical industry, an $80 billion global
market. Drug manufacturers are challenged by cost pressures, the need for
shorter production times and rapid scale-up, as well as bottlenecks in
downstream operations. At INTERPHEX2007, Pall Corporation (NYSE:  PLL) launches
several new technologies to provide the biopharmaceutical industry with tools
and systems to more efficiently manage their manufacturing processes. A leader
in filtration, separation and purification, Pall offers a comprehensive line
of integrated solutions for biopharmaceutical manufacturers from upstream to
downstream applications.

    "In the rapidly changing biopharmaceutical market, manufacturers must be
able to adapt quickly and effectively to sustain leadership," says Ken Frank,
President, Pall BioPharmaceuticals. "Our strong global presence and deep
portfolio of cutting-edge technologies provide customers with comprehensive
systems to help them efficiently optimize their drug production processes."

    Pall continues to champion the implementation of disposable processing
with the launch of its Allegro(TM) Systems, an integrated single-use
manufacturing solution, and its newest component, the Allegro Biocontainers
for collection and transport of process solutions, product intermediates and
cell culture media. Single-use technologies, employed by more than 90 percent
of biopharmaceutical manufacturers, provide cost, flexibility and quality
benefits. They increase efficiency by eliminating the need for cleaning and
cleaning validation and reduce cross-contamination risks.

    Pall Allegro Systems are gamma-irradiated and ready-for-use, facilitating
quick start-up and rapid scale-up to help accelerate time-to-market. These
qualities are becoming increasingly essential for the production of biotech
drugs and vaccines as well as for contract manufacturing organizations.

    The new Allegro Biocontainers feature a unique combination of design and
materials that help manufacturers maximize product recovery and minimize risk
of contamination. The comprehensive Allegro Systems portfolio includes
disposable filters, tubing and instant aseptic connection devices in addition
to the new biocontainers.

    With the new disposable Kleenpak(TM) TFF Microfiltration Capsule, Pall is
introducing the industry's first tangential flow filtration capsule.
Tangential flow filtration is used for clarifying, concentrating and purifying
proteins. A self-enclosed capsule, the Kleenpak TFF capsule helps improve
worker safety by limiting exposure to biologically active solutions. This is
an important consideration for manufacturers of vaccines and other potent
products that present potential workplace liabilities.

    To address the processing bottlenecks caused by higher protein
throughput, Pall strengthens its line of ultrafiltration technologies with the
introduction of the Omega(TM) T- Series Membrane Cassettes. The new cassettes
are constructed with high performance materials that reduce extractables and
assure effective mass transfer of proteins to deliver high-purity biological
solutions. The advanced filtration performance of the Omega T-Series cassettes
is also available in a disposable capsule format through the Minimate(TM) II
Capsule. This product easily scales with products in Pall's extensive line of
cassette technologies for truly integrated operations.

    About Pall Corporation

    Pall Corporation is the global leader in the rapidly growing field of
filtration, separation and purification. Pall is organized into two
businesses: Life Sciences and Industrial. These businesses provide
leading-edge products to meet the demanding needs of customers in
biotechnology, pharmaceutical, transfusion medicine, energy, electronics,
municipal and industrial water purification, aerospace, transportation and
broad industrial markets. Total revenues for fiscal year 2006 were $2.0
billion. The Company headquarters is in East Hills, New York with extensive
operations throughout the world. For more information visit Pall at

    Editor's Notes:

    --  Pall's technologies are on display at INTERPHEX2007 booth # 1819, at
the Jacob K. Javits Convention Center, New York, NY, April 24-26, 2007.

    --  Pall is hosting a press luncheon on Wednesday, April 25, 2007 at
12:00pm in room 1A18 at the Javits Convention Center.

    --  Downloadable, high-resolution images are available at


For further information:

For further information: Pall Corporation Marcia Katz, 516-801-9851
Director of Public Relations Fax: 516-484-3649 Email: Marcia_Katz@Pall.Com

Organization Profile


More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890